Danone Invests Further in Gut Health and Next-Generation Biotic ScienceWILMINGTON, Del., June 25, 2025 (GLOBE NEWSWIRE) -- The Akkermansia Company (TAC) today announces that it has been acquired ...

The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form.

Vives Partners has sold the Akkermansia Company (TAC), a specialist in biotics, to Danone. TAC develops health products based on the unique properties of the Akkermansia muciniphila commensal ...

VIVES Partners created The Akkermansia Company in 2016, from its outset bringing together a solid consortium of shareholders, including an €18M funding in 2018 with two key lead investors ...

TAC develops health products based on the unique properties of the Akkermansia muciniphila commensal bacterial species. The company has broad patents protecting the use of the Akkermansia species, ...

Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company. Danone today announces the acquisition of The Akkermansia Company, a ...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. Since she was very young, Dr. Dutta was passionate about the world ...